The Iktos Makya is a novel SaaS platform that employs AI-driven de novo drug design technology that focuses on Multi-Parametric Optimization (MPO). The platform is the first of its kind, offering an intuitive and user-friendly interface that enables the design of novel and easy-to-make compounds in line with multi-objective blueprints at unprecedented speed, performance, and diversity.

The Makya platform boasts multiple generative algorithms that cater to different use cases, ranging from hit discovery to lead optimization. These algorithms include the fine-tuning generator, novelty generator, and forward generator. The fine-tuning generator is designed to find optimal solutions within your chemical space in line with your project blueprint. The novelty generator, on the other hand, is optimized for discovering new ideas with high novelty for re-scaffolding/hit discovery. The forward generator is focused on designing a focused library of compounds easily accessible from commercial starting materials.

One of the notable features of the Makya platform is its seamless integration with Spaya, Iktos’ AI-driven synthetic planning technology. This integration provides a solution for synthetic accessibility concerns, ensuring that all promising ideas proposed by Makya are scored by Spaya to ensure that you can easily synthesize your next target compound.

For those who prefer coding over a fancy user interface, the Makya platform can also be operated using Python and easily integrated into your existing in-house machine learning workflows. The Makya Python UI, or PyMakya, provides a convenient and flexible solution for users who want more control over their design process.

The Makya platform is cloud-native, meaning that it runs as a SaaS platform in Iktos’ private infrastructure. However, the platform can easily be deployed in your virtual private cloud (AWS, Google cloud, Microsoft Azure) or on your premises. This flexibility makes it an ideal choice for users who require a more tailored and customized solution.

The Iktos Makya platform offers an innovative and user-friendly solution for AI-driven de novo drug design, delivering unprecedented speed, performance, and diversity. With its multiple generative algorithms, integration with Spaya, Python API, and cloud-native architecture, the Makya platform is well-suited for a broad range of use cases, from hit discovery to lead optimization.

Twitter Page of the Solution

linkedin Page of the Solution

Website of the Solution